Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for Bon Natural Life's Debt-to-EBITDA or its related term are showing as below:
BON'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -215.54 Med: 1 Max: 7.13
Current: -215.54
During the past 8 years, the highest Debt-to-EBITDA Ratio of Bon Natural Life was 7.13. The lowest was -215.54. And the median was 1.00.
BON's Debt-to-EBITDA is ranked worse than 100% of 1233
companies
in the Chemicals industry
Industry Median: 2.16
vs BON: -215.54
Bon Natural Life (NAS:BON) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
Bon Natural Life Debt-to-EBITDA Related Terms
Bon Natural Life Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Bon Natural Life's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BON vs SNES, YMAT, GLGI: Debt-to-EBITDA Comparison
For the Specialty Chemicals subindustry, Bon Natural Life's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bon Natural Life Debt-to-EBITDA vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Bon Natural Life's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bon Natural Life's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is two times the quarterly (Sep. 2025) EBITDA data.
Bon Natural Life (BON) has a Debt-to-EBITDA of -4.88 as of Sep. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bon Natural Life. According to the industry distribution chart, Bon Natural Life ranks #999999 out of 1233 companies in the Chemicals industry.
Is Bon Natural Life's Debt-to-EBITDA too high?
Bon Natural Life's current Debt-to-EBITDA is -4.88. Based on the distribution chart, Bon Natural Life ranks #999999 out of 1233 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Bon Natural Life has a GF Score™ of 42/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bon Natural Life's Debt-to-EBITDA compare to SNES and YMAT?
According to the Chemicals industry distribution chart, Bon Natural Life ranks #999999 out of 1233 companies for Debt-to-EBITDA. This places Bon Natural Life in the lower half of its industry. The industry median Debt-to-EBITDA is 2.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Chemicals company?
The median Debt-to-EBITDA among Chemicals companies is 2.16, based on 1,233 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on Bon Natural Life. For the Chemicals industry, the median Debt-to-EBITDA is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bon Natural Life's current Debt-to-EBITDA is -4.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bon Natural Life stock overvalued right now?
Based on GuruFocus' analysis, Bon Natural Life (BON) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.76, compared to a current price of $1.14 — trading 50% above its estimated fair value. The current Debt-to-EBITDA is -4.88. Bon Natural Life's overall GF Score™ is 42/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For Bon Natural Life (BON), the current Debt-to-EBITDA is -4.88 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bon Natural Life (BON) Overvalued in 2026?
Based on GuruFocus' analysis, Bon Natural Life stock appears to be overvalued.
The current stock price of $1.14 is trading 50% above its estimated GF Value™ of $0.76.
GuruFocus considers Bon Natural Life to be Significantly Overvalued.
Key valuation signals for BON:
Debt-to-EBITDA: -4.88
GF Value™: $0.76 vs. price of $1.14 (50% above fair value)
No single metric tells the full story. See the BON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bon Natural Life Ltd focuses on the manufacturing of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements by its customers. It has developed four technology platforms for large-scale separation, safety improvement, activity enhancement, and functional compounding of natural products. The company's offerings include Fragrance compounds, Health supplements, and Bioactive food ingredients. The company generates revenue from the sale of its products, the majority derived from the sale of Fragrance compounds, which include natural compounds extracted from plants for cosmetic applications.
42GF Score
Get the complete analysis for BON
Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BON has been successfully added to your 
